FLT3 and acute myeloid leukemia: Potential future strategies to overcome FLT3 inhibitor resistance in AML include the development of novel small-molecule FLT3 inhibitors, combination therapies involving FLT3 inhibitors, and the design of multi-target inhibitors [81-84].